Normal function · from ai-gene-review (P48436, commit 79fe13b38970) · AI-generated, not KB evidence

SOX9 is a SOXE-family transcription factor that plays dual core roles in development. First, SOX9 is the master regulator of chondrogenesis, cooperating with SOX5 and SOX6 to drive cartilage matrix gene expression (COL2A1, ACAN) and promoting chondrocyte differentiation while antagonizing osteoblast differentiation via beta-catenin inhibition. Second, SOX9 is critical for oligodendrocyte differentiation and glial fate specification, promoting glial over neuronal fates in the CNS. SOX9 binds AACAAT-centered DNA motifs via its HMG-box domain, bends DNA, and recruits co-activators CBP/p300 and TIP60. It functions exclusively in the nucleus with nuclear localization and export signals. Post-translational modifications including phosphorylation, acetylation, and sumoylation regulate its activity. While SOX9 has additional developmental roles in sex determination, heart valve, kidney, and other epithelial programs, its core molecular functions center on transcriptional activation in cartilage and glial lineages.

Nuclear transcriptional activation of the chondrogenic program, driving chondrocyte differentiation and cartilage development.
In the knowledge base · computed from kb/ at build time

Disorders

Relationship is the entry's genetic[].relationship_type. untyped means the entry has a genetic record for the gene but does not type it; its free-text association is shown instead.

DisorderRelationshipWhere the gene appears
46,XX testicular disorder of sex development causative germline
mechanism: SOX9 enhancer dosage gain
subtype: SRXX2
scoped to subtype: SRXX2
46,XY complete gonadal dysgenesis causative germline
mechanism: SRY-SOX9-SOX8-DMRT1 transcriptional network failure
subtype: SOX9-regulatory deletion complete gonadal dysgenesis
Campomelic Dysplasia causative germline
mechanism: Disrupted 46,XY Sex Determination; SOX9-Mediated Chondrogenesis Disruption
Isolated Pierre Robin Syndrome untyped
Regulatory target of pathogenic noncoding deletions in a subset of isolated Robin sequence
mechanism: Modular Loss of SOX9 Expression in Cranial Neural Crest
subtype: SOX9 regulatory
scoped to subtype: SOX9 regulatory
Fetal Valproate Syndrome no genetic record
mechanism: Disturbed Cranial Neural Crest Formation and Migration
ClinGen gene–disease validity · snapshot 2026-10-03 · matched to entries by MONDO

An entry matches when ClinGen's MONDO disease is the entry's own disease term, a subtype term, or an exact-match mapping. An amber status marks an entry ClinGen supports the gene for (Definitive, Strong or Moderate) whose own record does not type it. A Limited, Disputed or Refuted tier on such an entry is not a gap.

ClinGen diseaseMOIClassificationdismech entry
Cooks syndrome MONDO:0007134 AD Limited
2020-09-16
Cooks Syndrome not named
campomelic dysplasia MONDO:0007251 AD Definitive
2020-06-01
isolated Pierre-Robin syndrome MONDO:0009869 AD Limited
2024-08-06

Identity from HGNC (snapshot 2026-10-01). Page layers are described in the gene pages documentation.